Received Aug 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 1 | 030A21A | IM / LA |
Reported Symptoms: 10037087:PRURITUS; 10037844:RASH; Narrative: Patient received his first Moderna COVID-19 vaccine on 3/4/2021. Patient called the clinical contact center on 3/11/2021 reporting a rash on the left side of his neck the day after receiving the vaccine. Patient denied having difficulty breathing or swallowing, wheezing, pain, fevers or chills, nor nausea or vomiting. Patient reported self-treating of the rash with Caladryl clear that helped with reported symptoms, but requested additional medications to further help his rash. Patient was advised by the primary care team to take OTC diphenhydramine to help with the rash to which patient stated that it did help. Though, he still experienced a slight itch. Patient then presented to the centers Emergency Department on 3/16/2021 with complaints of continued rash with no relief from over-the-counter medications. Patient continued to deny having difficulty breathing or swallowing, wheezing, pain, fevers or chills, nor nausea or vomiting. No further workup was done for differential diagnoses. Patient was discharged from the ED with a prescription for hydrocortisone 2% topical cream, which helped with the itching. Of note, patient completed the Moderna COVID-19 vaccine series and had an 6 additional COVID-19 vaccine boosters (Moderna and Pfizer) with no complaints of itching and skin rash. Other Relevant HX: Other: